# AptarGroup, Inc. (ATR)

> Source: Nexqual · https://nexqual.com/ATR · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, AptarGroup, Inc. (ATR), nexqual.com/ATR" · informational, not investment advice.

**Price:** USD 128.1 (+1.97% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 125.63 · day 125.93–128.72 · 52w 103.23–146.91 · market cap $8.14B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $3.93B, net income $363M (9.2% margin), free cash flow $310M (SEC filings).
- Valuation: P/E 22.5x (avg 26.1x at the last 3 fiscal year-ends), EV/EBITDA 11.8x, net debt $1.14B.
- Insider open-market sales, last ~7 months: 9 Form 4 filings, $5.2M; 9 not under a Rule 10b5-1 plan ($5.2M); 4 by opportunistic insiders (4 outside 10b5-1 plans), 2 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.00 on a 1–5 scale) (9 analysts), mean target USD 162.25 (range 135–220).
- Total return with dividends: 1Y -0.9% vs S&P 500 +14.9%; 5Y +7.1% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 1.47, revenue estimate $981M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $3.23B | $3.32B | $3.49B | $3.58B | $3.78B | $3.93B |
| Operating income | $347M | $379M | $404M | $496M | $501M | $477M |
| Net income | $244M | $239M | $284M | $375M | $393M | $363M |
| EPS (diluted) | $3.61 | $3.59 | $4.25 | $5.53 | $5.89 | — |
| Free cash flow | $55.5M | $168M | $263M | $367M | $300M | $310M |
| Operating margin | 10.8% | 11.4% | 11.6% | 13.9% | 13.3% | 12.1% |
| Net margin | 7.6% | 7.2% | 8.2% | 10.5% | 10.4% | 9.2% |
| Revenue growth | +10.2% | +2.9% | +5.0% | +2.7% | +5.4% | — |
| Cash + short-term investments | $124M | $142M | $224M | $226M | $410M | — |
| Total debt | $1.05B | $1.17B | $1.06B | $864M | $1.32B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 22.5x · P/S 2.1x · EV/EBITDA 11.8x · EV/Sales 2.4x · P/FCF 26.2x · P/B 3.1x · FCF yield 3.81% · Earnings yield 4.45% · Dividend yield (paid, TTM) 1.51% · Buyback yield (TTM) 4.48% · Net debt $1.14B · EV $9.28B
P/E at fiscal year-ends: Dec 2025 20.7x, Dec 2024 28.4x, Dec 2023 29.1x.

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 9 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Vinczeller Shiela | Chief Human Resources Officer | 765 | $100K | 2.8% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-08-27 | Touya Gael | Segment Pres., CEO Designate | 3,740 | $500K | 11.4% | No | Too little history (no open-market trades in 2023) |
| 2026-08-04 | Prieur Marc | Segment President | 3,500 | $477K | 18.1% | No | Routine (sold in May each year 2023–2025; this trade is outside those months) |
| 2026-08-03 | Tanda Stephan B. | President and CEO | 9,838 | $1.3M | 3.9% | No | Too little history (no open-market trades in 2023) |
| 2026-08-03 | Tlili Hedi | Segment President | 8,854 | $1.2M | 36.5% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-06-09 | Prieur Marc | Segment President | 5,000 | $578K | 20.6% | No | Routine (sold in May each year 2023–2025; this trade is outside those months) |
| 2026-06-04 | Vinczeller Shiela | Chief Human Resources Officer | 3,555 | $400K | 11.6% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-26 | Gong Xiangwei | President, Asia | 4,200 | $488K | 26.9% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-07 | Hudson Irene Elizabeth | EVP and Chief Legal Officer | 1,264 | $156K | 46.1% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 9 analysts; mean target USD 162.25 (low 135, high 220).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-09 | UBS | Initiated | Neutral | $135 |
| 2026-08-03 | Wells Fargo | Target raised | Overweight | $145 → $155 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | -0.9% | +7.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -0.9% | +1.4% |
| Volatility (annualized) | 25.0% | 22.6% |
| Max drawdown | -22.9% (Feb 2026→Jun 2026) | -34.2% (Nov 2024→Jun 2026) |

## Peers (Medical Instruments & Supplies)
BLCO (Bausch + Lomb Corporation) USD 17.43 +1.46% · ALGN (Align Technology, Inc.) USD 155.51 +2.74% · RGEN (Repligen Corporation) USD 178.71 -0.72% · AVTR (Avantor, Inc.) USD 17.15 -0.64% · COO (The Cooper Companies, Inc.) USD 61.65 +4.54% · TFX (Teleflex Incorporated) USD 136.58 +4.74%

## More
Full page: https://nexqual.com/ATR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by business segment (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Pharma | $458.3M | 44.6% | +3.5% |
| Beauty | $377.4M | 36.8% | +10.3% |
| Closures | $202.6M | 19.7% | +6.5% |
| Total revenue | $1.03B | 100% | — |

## Revenue by region (quarter ended 2026-06-30)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Europe | $521.0M | 50.8% | +9.5% |
| Domestic | $292.0M | 28.4% | -5.7% |
| Asia | $128.4M | 12.5% | +23.3% |
| Latin America | $85.1M | 8.3% | +11.7% |
| Total revenue | $1.03B | 100% | — |

## Company outlook (8-K filed 2026-07-30)

- "Regarding Aptar's outlook, Tanda stated, "In alignment with Gael Touya, who will assume the role of CEO on September 1, we enter the third quarter with confidence."
- "Supported by our innovation pipeline and strong market positions, these trends support our outlook for the third quarter." 2 Aptar currently expects adjusted earnings per share for the third quarter of 2026 to be in the range of $1.45 to $1.53."
- "This guidance assumes an effective tax rate range of 22.5% to 24.5%."
- "The earnings per share guidance range is assuming a 1.14 Euro to USD exchange rate."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $1.47 | $1.46 | +0.6% | $980.8M | 8 |
| Next quarter (ends 2026-12-31) | $1.41 | $1.48 | -5.0% | $976.8M | 8 |
| Current fiscal year (ends 2026-12-31) | $5.49 | $5.49 | +0.2% | $3.97B | 8 |
| Next fiscal year (ends 2027-12-31) | $6.18 | $6.25 | -1.2% | $4.11B | 8 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-10-29): ±7.3%; last 8 reports averaged ±4.6%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 31.5% | ±7.3% |
| 2026-12-18 | 56 | 25.5% | ±8.2% |
| 2027-02-19 | 119 | 27.3% | ±12.5% |
| 2027-05-21 | 210 | 26.7% | ±16.2% |